Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy.
2d
News-Medical.Net on MSNCombination of RAS inhibition and immunotherapy provides breakthrough for pancreatic cancerAdding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...
Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...
Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...
4d
News-Medical.Net on MSNResearchers discover race-associated molecular differences in pancreatic tumorsResearchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...
Researchers from the VIB-KU Leuven Center for Cancer Biology, in collaboration with other scientists, have discovered a way ...
New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors.
A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...
An Indian origin scientist Vinod Balachandran, MD, in latest data from the phase 1 trial has revealed that an investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results